Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis

Autor: Montemurro, M.1 michael.montemurro@usz.ch, Gelderblom, H.2, Bitz, U.3, Schütte, J.4, Blay, J.Y.5, Joensuu, H.6, Trent, J.7,8, Bauer, S.9, Rutkowski, P.10, Duffaud, F.11, Pink, D.3
Zdroj: European Journal of Cancer. Mar2013, Vol. 49 Issue 5, p1027-1031. 5p.
Databáze: Academic Search Ultimate
Externí odkaz: